Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

India could potentially lose $6 billion or 0.16 per cent GDP in exports to the US at 10 per cent broad tariffs, with this ...

The Nifty Pharma index closed on a negative note on Tuesday. Shares of J B Chemicals & Pharmaceuticals Ltd.(up 3.03 per cent) ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Alembic Pharmaceuticals partners with Amlan International to bring innovative poultry health solutions to India's market.